Soros Fund Management’s ResMed RMD Stock Holding History

Soros Fund Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-12,800	Closed	-$687K	–	295
2015 Q4	$687K	Buy	+12,800	New	+$722K	0.01%	175

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Soros Fund Management's RMD Position: Q1 2016 in Review

Soros Fund Management sold out of ResMed (RMD) in Q1 2016, closing a stake of 12,800 shares — an estimated $687K sold.

Soros Fund Management first reported a position in RMD in Q4 2015 and held it in 1 quarter. The position peaked at $687K in Q4 2015. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2016.

Soros Fund Management reported no remaining ResMed position as of Q1 2016 after selling out during the quarter.
Soros Fund Management sold 12,800 ResMed shares in Q1 2016, an estimated $687K.
Soros Fund Management first reported a position in ResMed in Q4 2015 and held it in 1 quarter.
Soros Fund Management's ResMed position peaked at $687K in Q4 2015.
374 funds tracked by Wall St. Rank held ResMed as of Q1 2016.

Based on Soros Fund Management's 13F filing for Q1 2016, filed 16 May 2016.